Onset of clinical and MRI efficacy of ocrelizumab in relapsing multiple sclerosis

OBJECTIVE: To assess the onset of ocrelizumab efficacy on brain MRI measures of disease activity in the phase II study in relapsing-remitting multiple sclerosis (RRMS), and relapse rate in the pooled phase III studies in relapsing multiple sclerosis (RMS). METHODS: Brain MRI activity was determined...

Descripción completa

Detalles Bibliográficos
Autores principales: Barkhof, Frederik, Kappos, Ludwig, Wolinsky, Jerry S., Li, David K.B., Bar-Or, Amit, Hartung, Hans-Peter, Belachew, Shibeshih, Han, Jian, Julian, Laura, Sauter, Annette, Napieralski, Julie, Koendgen, Harold, Hauser, Stephen L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6946481/
https://www.ncbi.nlm.nih.gov/pubmed/31484710
http://dx.doi.org/10.1212/WNL.0000000000008189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6946481/
https://www.ncbi.nlm.nih.gov/pubmed/31484710
http://dx.doi.org/10.1212/WNL.0000000000008189

Ejemplares similares